Nuventra’s Brian Furmanski, PhD, will be speaking at this year’s Drug Metabolism Discussion Group (DMDG) Winter Symposium on February 27th at the Solution Center in Research Triangle Park, NC. Brian’s presentation is titled, “Regulatory Considerations for Cell and Gene Therapy.” The 2020 Winter Symposium will focus on the unique challenges of Genetic- and Cell-Based Therapies. Nuventra is a proud sponsor this year’s DMDG Winter Symposium.
When: February 27, 2020
Where: RTP Solution Center | 1101 Slater Rd | Durham, NC | 27703
Title: Genetic- and Cellular-based Therapies – Current Best Practices & Challenges
Registration: Must be received by Thursday, February 20th by sending confirmation/payment to Cindy Rewerts by email at email@example.com or by mail to PO Box 13864, RTP, NC 27709.
Other speakers include:
- Shawna Jackman Gangi, PhD, DABT – Charles River Laboratories
- Greg Falls, PhD, DABT and Cassie Gorsuch, PhD – Precision BioSciences
- Paul Korner, MD, MBA – Axovant Gene Therapies
More About DMDG:
The Research Triangle Park’s – DMDG is dedicated to fostering a continued discussion on the scientific advances in drug metabolism. The purpose of the organization is to encourage and enhance interactions among its professional members by providing a forum for scientific and professional engagement.